ArticleInternational journal of ophthalmology2026
Short-term results of 360° selective laser trabeculoplasty in patients with failed deep sclerectomy.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate the short-term results of 360° selective laser trabeculoplasty (SLT) in the treatment of patients with previously failed deep sclerectomy (DS).
methodsPatients with open angle glaucoma with prior failed DS and insufficient postoperative intraocular pressure (IOP) control were enrolled. Preoperative and postoperative IOP were measured using a Goldmann applanation tonometer. One hundred non-overlapping laser shots were applied over 360°. IOP was measured before SLT and 1h after SLT. Follow-up was scheduled at the first week and at the first, third, and sixth months thereafter.
resultsA total of 22 eyes (13 patients) were included in the study with a male:female ratio of 1:1 and a mean age of 51.73±13.51y (28-73y). The mean IOP prior to SLT was 18.41±5.24 mm Hg, which decreased to 15.91±3.56 (
conclusion360° SLT can be an effective complementary treatment after failed DS to decrease IOP and anti-glaucoma medications, thus improving patient compliance and tolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.